Adaptive Biotechnologies Corp
F:1HM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Adaptive Biotechnologies Corp
F:1HM
|
US |
|
Askul Corp
OTC:ASKLF
|
JP |
|
B
|
Banca Sistema SpA
F:B2S
|
IT |
|
C
|
Coca-Cola Co
XHAN:CCC3
|
US |
|
L B Foster Co
NASDAQ:FSTR
|
US |
|
S
|
Surteco Group SE
XMUN:SUR
|
DE |
|
A
|
Adidas AG
XHAN:ADS
|
DE |
|
R
|
RF Industries Ltd
F:RF5
|
US |
|
S
|
Sporton International Inc
TPEX:6146
|
TW |
|
F
|
First Phosphate Corp
OTC:FRSPF
|
CA |
|
G
|
Galectin Therapeutics Inc
SWB:PHPN
|
US |
|
V
|
Vectron Systems AG
F:V3S
|
DE |
|
H
|
Hulic Co Ltd
F:87W
|
JP |
|
J
|
Janus Henderson Group PLC
F:HDJA
|
UK |
|
G
|
Galectin Therapeutics Inc
F:PHPN
|
US |
|
D
|
Dynasty Ceramic PCL
SET:DCC
|
TH |
|
COSCIENS Biopharma Inc
OTC:CSCID
|
CA |
|
ACQ Bure AB
F:0FE
|
SE |
|
Nickel Industries Ltd
F:NM5
|
AU |
|
Universal Display Corp
NASDAQ:OLED
|
US |
|
S
|
Surteco Group SE
F:SUR
|
DE |
|
Masi Agricola SpA
F:0CY
|
IT |
|
B
|
Beowulf Mining PLC
F:B4E
|
UK |
|
B
|
Brembo SpA
F:BRCA
|
IT |
Wall St Price Targets
1HM Price Targets Summary
Adaptive Biotechnologies Corp
According to Wall Street analysts, the average 1-year price target for 1HM is 55.226 EUR with a low forecast of 48.015 EUR and a high forecast of 61.01 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1HM's stock price target?
Price Target
55.226
EUR
According to Wall Street analysts, the average 1-year price target for 1HM is 55.226 EUR with a low forecast of 48.015 EUR and a high forecast of 61.01 EUR.
What is the Revenue forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 5 years is 19%.
What is the Gross Profit forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 28%. The projected CAGR for the next 5 years is 19%.
